查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003127

伴侶動物診斷市場：2026-2032年全球市場預測（依診斷測試類型、產品類型、動物種類、最終用戶和應用分類）

Companion Animal Diagnostics Market by Type Of Diagnostic Test, Product Type, Animal Type, End-User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，寵物診斷市場價值將達到 35.9 億美元，到 2026 年將成長到 39 億美元，到 2032 年將達到 65.5 億美元，複合年成長率為 8.94%。

主要市場統計數據
基準年 2025 35.9億美元
預計年份：2026年 39億美元
預測年份 2032 65.5億美元
複合年成長率 (%) 8.94%

對不斷發展的伴侶動物診斷領域進行簡要概述，重點關注正在重塑我們提供護理方式的技術、臨床和監管促進因素。

伴侶動物診斷領域正經歷著快速變革時期，這主要得益於技術創新、臨床實踐的改變以及飼主對更精準、更快捷的獸醫服務的日益成長的期望。檢測設計、影像技術和分子技術的進步使得疾病的早期發現、更個人化的治療方案以及對治療效果的更佳監測成為可能。隨著獸醫院採用更先進的院內檢測能力，即時篩檢（POC​​）和檢查室診斷之間的界線日益模糊，獸醫院和專科中心的流程模式和服務提供方式也在不斷重組。

這清楚地概述了將改變整體診斷技術、臨床工作流程和經營模式的關鍵變革。

伴侶動物診斷領域正經歷一場變革，多項變革共同推動著產業提案的重塑。首先，分子診斷和次世代定序的成熟使得診斷工具包超越了傳統的形態學和血清學檢測，能夠實現病原體的精準鑑定、遺傳風險分析和標靶腫瘤檢測。同時，即時檢測技術和小型分析儀的普及使得檢測分散化，許多診所能夠在內部進行血液檢測、生物化學檢驗和快速感染疾病檢測。這縮短了診斷時間，並促進了即時的臨床干預。

對 2025 年關稅調整將如何影響供應鏈韌性、區域籌資策略和臨床醫生採購行為進行實際分析。

計劃於2025年實施的關稅調整和貿易政策變化，為伴侶動物診斷供應鏈中的製造商、經銷商和終端用戶帶來了新的營運挑戰。某些市場對醫療設備和試劑徵收更高的關稅，給依賴全球採購的供應商的利潤率帶來了壓力，迫使他們重新評估其分銷策略、定價模式和供應商關係。擁有地理位置分散的生產基地和靈活的契約製造安排的製造商，更有能力緩解短期成本壓力，並穩定向獸醫院和檢查室供應的供應鏈。

詳細的細分洞察揭示了診斷測試類型、產品類型、目標動物群、最終用戶環境和臨床應用如何塑造策略重點。

精細化的細分觀點能夠清楚地展現臨床需求、技術適用性和商業性機會在多個診斷類別中的交會點。 「診斷測試類型」維度涵蓋血液學測試，例如血液凝固檢查和血液常規檢查；組織病理學方法，包括切片檢查和細胞學工作流程；影像學方法，涵蓋超音波和X光診斷；分子診斷平台，從DNA定序到基於PCR的檢測；以及血清學方法，包括凝集試驗和ELISA。每種測試類型都有其獨特的分析要求、檢體處理程序和培訓需求，這些都會影響獸醫醫院和檢測實驗室的採購決策。

戰略區域洞察，闡述美洲、歐洲、中東和非洲以及亞太市場在技術採用、監管和經營模式方面的差異。

區域趨勢對技術採納、監管路徑和商業性實施策略有顯著影響。在美洲，專業獸醫診所和先進實驗室的集中分佈，以及完善的分銷網路和成熟的私人診所生態系統，正推動著高通量分子診斷和整合臨床管理流程的快速普及。相較之下，歐洲、中東和非洲（EMEA）的情況則更為複雜，監管協調的努力與市場分散並存。西歐成熟的獸醫中心推動了對檢驗和認證的解決方案的需求，而新興市場則優先考慮能夠應對區域疾病負擔且經濟高效、適應性強的診斷方案。

從企業層面提供實用見解，重點介紹競爭差異化策略、合作途徑和創新重點，以維持永續的市場地位。

隨著老牌製造商、專業儀器製造商、試劑供應商和創新分子診斷公司尋求差異化的價值提案，伴侶動物診斷領域的競爭動態正在不斷演變。成功越來越依賴整合式交付系統，該系統需結合可靠的儀器和檢驗的耗材、精簡的工作流程以及完善的售後服務支援。投資於臨床證據、第三方檢驗和跨物種參考數據的公司能夠贏得獸醫和檢查室管理人員的信任，有助於維持長期的採購合作關係。

為行業領導者提供切實可行的、優先考慮的建議，以協調產品、證據、定價和分銷策略，從而促進臨床引入和發展。

產業領導者可以透過調整產品、證據和市場策略以適應不斷變化的臨床需求，從而採取果斷行動，將市場動態轉化為競爭優勢。首先，他們應優先考慮模組化產品架構，該架構允許從基礎血液學和生物化學檢驗擴展到更高級的分子和血清學檢測，而無需巨額資本投入。這種方法降低了採用門檻，並透過升級途徑促進了與客戶的長期關係。同時，他們應投資於可靠的臨床檢驗研究和跨物種比較參考數據，以證明其分析表現和在最常見伴侶動物群體中的臨床效用。

透明的調查方法，解釋資訊來源、專家參與、分析框架和局限性，以支持策略見解。

本分析的研究基礎包括對同行評審的獸醫臨床文獻、監管指導文件和產品技術規範進行系統性回顧，並結合對檢查室管理人員、獸醫、分銷商和產品經理的直接訪談。在資料整合過程中，研究重點在於透過交叉檢驗多個資訊來源，檢驗技術能力、工作流程影響和區域部署模式。專家定性見解有助於解讀臨床效用和操作可行性，而二手資料則提供了有關監管和供應鏈趨勢的背景資訊。

簡明扼要地總結了伴侶動物診斷領域策略定位的技術、監管和商業性要求。

總之，伴侶動物診斷產業正處於策略轉折點，技術進步、照護模式演變、監管政策調整和經濟壓力等因素相互作用，正在重塑其價值創造模式。分子層面的創新、增強的照護現場能力以及整合的數位化工作流程，在提高診斷準確性的同時，也改變了與傳統檢查室服務的關係。同時，政策措施和關稅調整正促使供應商和經銷商重新評估籌資策略，並增強區域供應鏈的韌性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 伴侶動物診斷市場：診斷測試類型

  • 血液學
    • 血液凝固檢查
    • 血液常規檢查（CBC）
  • 組織病理學
    • 切片檢查
    • 細胞學
  • 診斷影像
    • 超音波檢查
    • X光
  • 分子診斷
    • DNA定序
    • PCR
  • 血清學
    • 聚集反應
    • ELISA檢測

第9章 伴侶動物診斷市場：依產品類型分類

  • 消耗品
    • 試劑
    • 檢測套組
  • 設備/分析儀
    • 臨床化學分析儀
    • 血液檢測設備
    • 免疫診斷分析儀
    • 分子診斷分析儀

第10章 伴侶動物診斷市場：依動物類型分類

  • 鳥類
  • 貓
  • 狗
  • 天竺鼠
  • 馬

第11章 伴侶動物診斷市場：依最終使用者分類

  • 院內檢測設施
    • 動物收容所
    • 寵物飼主
  • 研究所
  • 獸醫醫院和診所

第12章 伴侶動物診斷市場：依應用領域分類

  • 內分泌檢查
  • 基因檢測
  • 感染疾病診斷
  • 營養分析
  • 腫瘤學
  • 藥物監測
  • 毒性測試

第13章 伴侶動物診斷市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 伴侶動物診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 伴侶動物診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國伴侶動物診斷市場

第17章：中國伴侶動物診斷市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agrolabo SpA
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Demeditec Diagnostics GmbH
  • Eurofins Technologies
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Mars, Incorporated
  • Neogen Corporation
  • Nisseiken Co., Ltd
  • Qiagen NV
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-AD517FAA89C5

The Companion Animal Diagnostics Market was valued at USD 3.59 billion in 2025 and is projected to grow to USD 3.90 billion in 2026, with a CAGR of 8.94%, reaching USD 6.55 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.59 billion
Estimated Year [2026] USD 3.90 billion
Forecast Year [2032] USD 6.55 billion
CAGR (%) 8.94%

A concise orientation to the evolving companion animal diagnostics environment highlighting technological, clinical, and regulatory drivers reshaping care

The companion animal diagnostics landscape is undergoing a period of accelerated transformation driven by converging technological innovation, shifting clinical practices, and heightened owner expectations for more precise and timely veterinary care. Advances in assay design, imaging modalities, and molecular techniques are enabling earlier detection of disease, more personalized treatment pathways, and improved monitoring of therapeutic outcomes. As veterinary practices adopt more sophisticated in-house testing capabilities, the boundary between point-of-care screening and laboratory-grade diagnostics continues to blur, reshaping workflow models and service offerings across clinics and specialty centers.

Regulatory frameworks and professional guidelines are evolving in parallel, influencing validation standards, quality control expectations, and data governance practices for diagnostic tools and services. This dynamic regulatory context is prompting manufacturers and service providers to strengthen their evidence generation, claim substantiation, and post-market surveillance activities. Meanwhile, stakeholder expectations-from clinicians seeking rapid clinical decision support to pet owners demanding transparency and continuity of care-are incentivizing interoperable systems, standardized reporting formats, and clearer outcome metrics.

Taken together, these forces are redefining competitive differentiation. Companies that combine robust analytical performance with seamless integration into clinical workflows, strong customer support, and demonstrable clinical utility will secure the most durable positions in the market. The introduction sets the stage for a focused examination of these transformative shifts and their implications for players across the diagnostics ecosystem.

Clear articulation of the major transformative shifts altering diagnostic technologies, clinical workflows, and commercial models across veterinary practice

The landscape for companion animal diagnostics is being reshaped by several transformative shifts that are converging to redefine value propositions across the industry. First, the maturation of molecular diagnostics and next-generation sequencing has expanded the diagnostic toolkit beyond traditional morphology and serology, enabling precise pathogen identification, genetic risk profiling, and targeted oncology testing. Concurrently, point-of-care technologies and compact analyzers are decentralizing testing, allowing many practices to perform hematology, chemistry, and rapid infectious disease assays on-site, which shortens time-to-diagnosis and facilitates immediate clinical interventions.

Informatics and data integration are also rising to the fore. Cloud-based platforms, laboratory information systems, and diagnostic middleware are improving sample tracking, result interpretation, and longitudinal patient monitoring. This digital layer supports decision support algorithms and facilitates remote consultations, telemedicine follow-ups, and population-level surveillance of emerging pathogens. Additionally, growing adoption of standardized quality controls and accreditation programs is raising baseline expectations for analytical robustness across providers, which in turn influences procurement decisions and client trust.

Finally, economic and service delivery models are evolving: subscription-based service arrangements for reagents and consumables, bundled diagnostic packages, and value-based contracting for companion diagnostics are emerging as strategic approaches for suppliers. Organizations that embed clinical evidence generation, workflow integration, and responsive service models into their offerings will be better positioned to capture clinician adoption and long-term account relationships.

Practical analysis of how 2025 tariff adjustments are influencing supply chain resilience, regional sourcing strategies, and clinician procurement behavior

Tariff adjustments and trade policy changes slated for 2025 are creating a new set of operational considerations for manufacturers, distributors, and end-users in the companion animal diagnostics supply chain. Increased import duty levels on medical devices and reagents in select markets have compressed margins for vendors that rely on global sourcing, prompting a re-evaluation of distribution strategies, pricing models, and supplier relationships. Manufacturers with geographically diversified production footprints or flexible contract manufacturing arrangements are better able to mitigate near-term cost pressures and stabilize supply commitments to veterinary clinics and laboratories.

Beyond immediate cost implications, tariffs are catalyzing strategic shifts in supply chain architecture. Some suppliers are accelerating localization of component production and final assembly to reduce exposure to cross-border duties and shipping disruptions. This localization trend is influencing lead times, inventory policies, and capital investment decisions for facility expansions or partnerships. For end-users, procurement teams are revisiting total-cost-of-ownership calculations that incorporate tariff-driven price volatility, freight, and customs-related delays.

At the same time, tariff-driven market dynamics are influencing clinical adoption patterns. Where imported diagnostic platforms become less price-competitive, regional alternatives and modular in-house assay development may gain traction, especially in larger veterinary hospitals and research centers with capacity to validate new assays. Strategic collaboration between manufacturers and distributors to bundle services, offer extended warranties, and provide training can offset perceived cost increases and maintain continuity of clinical services amidst tariff-related uncertainty.

In-depth segmentation insights revealing how diagnostic test types, product classes, animal cohorts, end-user settings, and clinical applications shape strategic priorities

A granular segmentation lens clarifies where clinical need, technology fit, and commercial opportunity intersect across multiple diagnostic categories. The Type Of Diagnostic Test dimension includes hematology tests such as blood clotting assays and complete blood count panels, histopathology procedures encompassing both biopsy and cytology workflows, imaging modalities that cover ultrasound and X-ray diagnostics, molecular platforms spanning DNA sequencing and PCR-based assays, and serology approaches including agglutination assays and ELISA tests. Each test type carries distinct analytical requirements, specimen handling protocols, and training needs, which influence purchasing decisions across veterinary practices and reference laboratories.

Product Type segmentation differentiates consumables from instruments and analyzers, with consumables further characterized by reagents and test kits and instruments defined by categories such as clinical chemistry analyzers, hematology analyzers, immunodiagnostic analyzers, and molecular diagnostic instruments. This split underscores the divergent procurement rhythms between recurring reagent spend and capital expenditures for analyzers, shaping revenue models and sales strategies for suppliers.

Animal Type spans birds, cats, dogs, guinea pigs, and horses, and this diversity necessitates assay validation across species-specific reference ranges, sample matrix considerations, and clinical interpretation frameworks. End-User segmentation covers in-house testing facilities, research laboratories, and veterinary hospitals and clinics, with in-house testing facilities further segmented into animal shelters and pet owners, reflecting varying resource envelopes and technical capabilities. Application-focused segmentation includes areas such as endocrinology testing, genetic testing, infectious disease diagnostics, nutritional analysis, oncology, therapeutic drug monitoring, and toxicology testing; each application drives unique feature sets, regulatory needs, and evidence demands. Recognizing these intersecting segmentation vectors helps stakeholders prioritize product roadmaps, validation studies, and tailored commercial approaches for distinct end-user cohorts.

Strategic regional insights explaining how Americas, Europe Middle East & Africa, and Asia-Pacific markets diverge in adoption, regulation, and commercial models

Regional dynamics exert a powerful influence on technology adoption, regulatory pathways, and commercial execution strategies. In the Americas, a concentration of specialty veterinary practices and advanced reference laboratories favors rapid uptake of high-throughput molecular diagnostics and integrated practice-management workflows, supported by established distribution networks and a mature private practice ecosystem. In contrast, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with market fragmentation; established veterinary centers in Western Europe drive demand for validated, accredited solutions while emerging markets prioritize cost-effective, adaptable diagnostic options that address regional disease burdens.

In the Asia-Pacific region, rapid urbanization, growing pet ownership, and expanding veterinary education infrastructure are catalyzing demand for both point-of-care testing and advanced laboratory services. Local manufacturing and regional partnerships are increasingly important in Asia-Pacific, enabling faster market entry and responsiveness to price sensitivity. Across all regions, differences in reimbursement models, clinic consolidation trends, and professional training programs shape the pace and pattern of diagnostic uptake. Vendors must tailor their market entry strategies to account for these regional nuances, balancing standardized global product platforms with region-specific regulatory compliance, distribution frameworks, and service models to achieve sustainable adoption.

Actionable company-level insights highlighting competitive differentiation strategies, partnership pathways, and innovation priorities for sustained market relevance

Competitive dynamics within the companion animal diagnostics space are evolving as incumbent manufacturers, specialized instrument makers, reagent suppliers, and innovative molecular diagnostics firms seek differentiated value propositions. Success increasingly depends on integrated offerings that couple reliable instruments with validated consumables, streamlined workflows, and strong after-sales support. Companies that invest in clinical evidence generation, third-party validations, and cross-species reference data establish credibility with veterinary clinicians and laboratory directors, which helps sustain long-term procurement relationships.

Collaboration and strategic partnerships are emerging as effective pathways to accelerate market penetration. Alliances that combine diagnostic expertise with digital health platforms, telemedicine providers, or practice-management systems create compelling bundled solutions that address clinician workflow pain points and improve patient outcome tracking. Additionally, organizations that invest in training, remote diagnostics support, and technical service networks reduce adoption friction and enhance customer retention.

Innovation in reagent chemistry, microfluidics, and portable instrumentation is opening new competitive fronts where speed, ease of use, and assay robustness determine clinician preference. Firms that align product development with end-user realities-such as limited bench space, variable sample volumes, and the need for rapid actionable results-will command stronger market relevance. Finally, transparent post-market surveillance and responsiveness to regulatory developments reinforce trust and reduce adoption barriers for newer technologies.

Practical and prioritized recommendations for industry leaders to align product, evidence, pricing, and distribution strategies for clinical adoption and growth

Industry leaders can act decisively to convert market dynamics into competitive advantage by aligning product, evidence, and go-to-market strategies with evolving clinical needs. First, prioritize modular product architectures that allow clinics to scale capabilities from basic hematology and chemistry to more advanced molecular and serology testing without prohibitive capital outlays. This approach reduces adoption barriers and supports long-term customer relationships through upgrade pathways. In parallel, invest in robust clinical validation studies and cross-species reference data to demonstrate analytical performance and clinical utility across the most common companion animal cohorts.

Commercially, adopt flexible contracting models that combine capital equipment leasing, reagent subscription programs, and bundled service offerings to match the financial capacities of diverse end-users, from small clinics to large referral centers. Strengthen regional distribution by cultivating local manufacturing or assembly partnerships where tariff exposure or logistical constraints could undermine competitiveness. Complement product availability with targeted training programs, remote technical support, and quality assurance resources to minimize implementation friction and maximize clinician confidence.

Finally, integrate digital capabilities that enhance result interpretation, data sharing, and longitudinal patient tracking. Provide interoperable reporting formats that plug into practice-management systems and enable telemedicine workflows. By focusing on modularity, evidence generation, customer support, and digital integration, industry leaders will be positioned to capture long-term value as the companion animal diagnostics environment continues to mature.

Transparent research methodology explaining sources, expert engagement, analytical frameworks, and limitations to underpin the strategic findings

The research underpinning this analysis combined a structured review of peer-reviewed veterinary clinical literature, regulatory guidance documents, product technical specifications, and primary interviews with laboratory directors, veterinary clinicians, distributors, and product managers. Data synthesis emphasized triangulation across multiple sources to validate technology capabilities, workflow impacts, and regional adoption patterns. Qualitative inputs from subject-matter experts informed interpretation of clinical utility and operational feasibility, while secondary sources provided context on regulatory trajectories and supply chain dynamics.

Analytical methods included comparative feature mapping of diagnostic platforms, evaluation of assay validation approaches across species, and scenario analysis to assess tariff-driven supply chain responses. Emphasis was placed on reproducibility of findings and transparency of assumptions; where expert opinion informed projections about adoption likelihood or operational impacts, those judgements were corroborated with multiple practitioner interviews. Limitations include evolving regulatory actions and fast-moving technological developments that may shift dynamics after publication; accordingly, readers are encouraged to consider this research as a strategic compass that should be complemented with ongoing market monitoring and targeted validation in local practice settings.

The methodological approach ensures that the insights presented are grounded in practitioner realities, validated technical characteristics, and pragmatic commercial considerations, enabling decision-makers to apply findings to product development, procurement, and clinical integration strategies.

Concise conclusion synthesizing technological, regulatory, and commercial imperatives for strategic positioning in companion animal diagnostics

In conclusion, companion animal diagnostics stands at a strategic inflection point where technological advances, shifting care models, regulatory evolution, and economic pressures intersect to reshape value creation. The combination of molecular innovations, improved point-of-care capabilities, and integrated digital workflows is enhancing diagnostic precision while altering traditional laboratory-service relationships. Simultaneously, policy measures and tariff adjustments are prompting suppliers and distributors to reassess sourcing strategies and to strengthen regional supply resilience.

For stakeholders across the ecosystem, the path forward involves aligning product innovation with validated clinical utility, structuring commercial models that reflect end-user financial realities, and investing in service frameworks that reduce adoption friction. Regional nuance matters: targeted market approaches that consider local regulatory environments, distribution infrastructures, and clinical practice patterns will outperform one-size-fits-all strategies. Ultimately, organizations that balance technical excellence with pragmatic commercialization-backed by evidence, training, and responsive support-will lead the next phase of adoption and deliver measurable clinical and business value.

This conclusion synthesizes the principal insights and underscores the imperative for proactive strategy development to capture opportunity and mitigate operational risk in a rapidly evolving diagnostics environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Companion Animal Diagnostics Market, by Type Of Diagnostic Test

  • 8.1. Hematology
    • 8.1.1. Blood Clotting Test
    • 8.1.2. Complete Blood Count (CBC)
  • 8.2. Histopathology
    • 8.2.1. Biopsy
    • 8.2.2. Cytology
  • 8.3. Imaging
    • 8.3.1. Ultrasound
    • 8.3.2. X-Rays
  • 8.4. Molecular Diagnostics
    • 8.4.1. DNA Sequencing
    • 8.4.2. PCR
  • 8.5. Serology
    • 8.5.1. Agglutination Assay
    • 8.5.2. Elisa Test

9. Companion Animal Diagnostics Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Reagents
    • 9.1.2. Test kits
  • 9.2. Instruments/Analyzers
    • 9.2.1. Clinical chemistry analyzers
    • 9.2.2. Hematology analyzers
    • 9.2.3. Immunodiagnostic analyzers
    • 9.2.4. Molecular diagnostic analyzers

10. Companion Animal Diagnostics Market, by Animal Type

  • 10.1. Birds
  • 10.2. Cats
  • 10.3. Dogs
  • 10.4. Guinea pigs
  • 10.5. Horses

11. Companion Animal Diagnostics Market, by End-User

  • 11.1. In-House Testing Facilities
    • 11.1.1. Animal Shelters
    • 11.1.2. Pet Owners
  • 11.2. Research Laboratories
  • 11.3. Veterinary Hospitals & Clinics

12. Companion Animal Diagnostics Market, by Application

  • 12.1. Endocrinology Testing
  • 12.2. Genetic Testing
  • 12.3. Infectious Disease Diagnostics
  • 12.4. Nutritional Analysis
  • 12.5. Oncology
  • 12.6. Therapeutic Drug Monitoring
  • 12.7. Toxicology Testing

13. Companion Animal Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Companion Animal Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Companion Animal Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Companion Animal Diagnostics Market

17. China Companion Animal Diagnostics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agrolabo S.p.A.
  • 18.6. Bio-Rad Laboratories, Inc.
  • 18.7. Biogal Galed Labs
  • 18.8. BioMerieux S.A.
  • 18.9. BioNote, Inc.
  • 18.10. Demeditec Diagnostics GmbH
  • 18.11. Eurofins Technologies
  • 18.12. Fassisi GmbH
  • 18.13. FUJIFILM Holdings Corporation
  • 18.14. IDEXX Laboratories, Inc.
  • 18.15. IDvet
  • 18.16. Mars, Incorporated
  • 18.17. Neogen Corporation
  • 18.18. Nisseiken Co., Ltd
  • 18.19. Qiagen N.V.
  • 18.20. Randox Laboratories, Ltd.
  • 18.21. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 18.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 18.23. SKYER, Inc.
  • 18.24. Skyla Corporation
  • 18.25. Thermo Fisher Scientific Inc.
  • 18.26. Vimian Group AB
  • 18.27. Virbac S.A.
  • 18.28. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BLOOD CLOTTING TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COMPLETE BLOOD COUNT (CBC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY X-RAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY AGGLUTINATION ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ELISA TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GUINEA PIGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HORSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ENDOCRINOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TOXICOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 265. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 266. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 272. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 275. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY TYPE OF DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY SEROLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS COMPANION ANIMAL DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-20